Zepbound $1,399/month (limited availability, subject to clinical approval) Insurance: Not required
Supporting the NO system may help maintain that "Goldilocks" pace of digestion
10.3390/antiox10030414 Summary Keywords semaglutide, inflammation, C-reactive protein, glucagon-like peptide-1 receptor agonists, meta-analysis Citation Masson W, Lobo M, Nogueira JP, Rodriguez-Granillo AM, Barbagelata LE and Siniawski D (2024) Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis
The generic name for the drug compound developed by Novo Nordisk
Semaglutide 2.4mg can achieve weight loss of approximately 10-15% of initial body weight over 12-18 months, while liraglutide 3mg typically produces more modest results of about 5-8% weight loss